Acta Neurologica Scandinavica

Epileptogenesis and rational therapeutic strategies
pp. 139-155(17)
Authors: Stefan, H.; Lopes da Silva, F. H.; Löscher, W.; Schmidt, D.; Perucca, E.; Brodie, M. J.; Boon, P. A. J. M.; Theodore, W. H.; Moshé, S. L.

Patient satisfaction with an injection device for multiple sclerosis treatment
pp. 156-162(7)
Authors: Cramer, J. A.; Cuffel, B. J.; Divan, V.; Al-Sabbagh, A.; Glassman, M.

Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation
pp. 163-166(4)
Authors: Elovaara, I.; Kuusisto, H.; Paalavuo, R.; Särkijärvi, S.; Lehtimäki, T.; Huhtala, H.; Vilpo, J.

Factors affecting the quality of life in childhood epilepsy in China
pp. 167-173(7)
Authors: Yong, L.; Chengye, J.; Jiong, Q.

Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma
pp. 174-177(4)
Authors: Verma, A.; Misra, S.

Centralized rehabilitation after severe traumatic brain injury – a population-based study
pp. 178-184(7)
Authors: Engberg, A. W.; Liebach, A.; Nordenbo, A.

IgM-containing fraction suppressed voltage-gated potassium channels in acquired neuromyotonia
pp. 185-188(4)
Authors: Kurono, A.; Arimura, K.; Watanabe, O.; Tomimitsu, H.; Nagado, T.; Sonoda, Y.; Kameyama, M.; Osame, M.

d-Amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model
pp. 189-198(10)
Authors: Rasmussen, R. S.; Overgaard, K.; Hildebrandt-Eriksen, E. S.; Boysen, G.

Headaches and the N95 face-mask amongst healthcare providers
pp. 199-202(4)
Authors: Lim, E. C. H.; Seet, R. C. S.; Lee, K.-H.; Wilder-Smith, E. P. V.; Chuah, B. Y. S.; Ong, B. K. C.

Crossed–uncrossed difference (CUD) in a new light: anatomy of the negative CUD in Poffenberger's paradigm
pp. 203-208(6)
Author: Derakhshan, I.

Announcement
pp. 209-209(1)